Literature DB >> 468841

The sugar chains of cold-insoluble globulin. A protein related to fibronectin.

S Takasaki, K Yamashita, K Suzuki, S Iwanaga, A Kobata.   

Abstract

Cold-insoluble globulin isolated from bovine plasma contains six asparagine-linked sugar chains in 1 molecule (a dimeric form). These sugar chains were released from the polypeptide backbone by hydrazinolysis and labeled by reduction with NaB[3H]4. Most of these sugar chains contain N-acetylneuraminic acid and can be separated by paper electrophoresis. By combination of sequential exoglycosidase digestion and methylation study, their structures were elucidated as Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(NeuAc alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc beta 1 leads to 4GlcNAc, NeuAc alpha 2 leads to 6 or 4Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(NeuAc alpha 2 leads to 4 or 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc beta 1 leads to 4GlcNAc, NeuAc alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6[NeuAc alpha 2 4Gal beta 1 leads to 3(NeuAc alpha 2 leads to 6)GlcNAc beta 1 leads to 2Man alpha 1 leads to 3]-Man beta 1 leads to 4GlcNAc beta 1 leads to 4GlcNAc and NeuAc alpha 2 leads to 4Gal beta 1 leads to 3(NeuAc alpha 2 leads to 6)GlcNAc beta 1 leads to 2Man alpha 1 leads to 6[NeuAc alpha 2 leads to 4Gal beta 1 leads to 3(NeuAc alpha 2 leads to 6)GlcNAc beta 1 leads to 2Man alpha 1 leads to 3]man beta 1 leads to 4GlcNAc beta 1 leads to 4GlcNAc.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Targeting and glycosylation of patatin the major potato tuber protein in leaves of transgenic tobacco.

Authors:  U Sonnewald; A Sturm; M J Chrispeels; L Willmitzer
Journal:  Planta       Date:  1989-09       Impact factor: 4.116

2.  FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes.

Authors:  E V Sokurenko; H S Courtney; D E Ohman; P Klemm; D L Hasty
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

3.  Interaction of viral envelope glycoproteins with fibronectin.

Authors:  I Julkunen; A Hautanen; J Keski-Oja
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

Review 4.  Structure, biosynthesis and functions of glycoprotein glycans.

Authors:  E G Berger; E Buddecke; J P Kamerling; A Kobata; J C Paulson; J F Vliegenthart
Journal:  Experientia       Date:  1982-10-15

5.  Comparative studies on amniotic fluid and plasma fibronectins.

Authors:  E Ruoslahti; E Engvall; E G Hayman; R G Spiro
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

6.  Synthesis and glycosylation of fibronectin in hepatocytes from vitamin A-deficient rats.

Authors:  M J Kirven; G Wolf
Journal:  Mol Cell Biochem       Date:  1991-03-13       Impact factor: 3.396

7.  Fibronectin--mediator between cells and connective tissue.

Authors:  H Hörmann
Journal:  Klin Wochenschr       Date:  1982-10-15

8.  Comparative rates of transfer of N-acetylneuraminic acid to acceptors bearing one or more Gal(beta 1-4)GlcNAc terminus by the Gal(beta 1-4)GlcNAc(NeuAc-Gal) (alpha 2-6)-sialyltransferase from embryonic chicken liver. Utilization of oligosaccharides as acceptors in sialyltransferase assays.

Authors:  B Bendiak; G M Cook
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

9.  Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants.

Authors:  M A Markwell; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Deposition of plasma fibronectin in tissues.

Authors:  E Oh; M Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.